1-2 of 2
Armand Bankhead
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers

Joel D. Maust, Christy L. Frankowski-McGregor, Armand Bankhead, III, Diane M. Simeone, Judith S. Sebolt-Leopold
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (12): 2495–2506.
https://doi.org/10.1158/1535-7163.MCT-18-0082
Published: 03 December 2018
View article titled, Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers
Open the PDF for Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes.

Sean Eddy, Mark Tomilo, Mary Ellen Urick, Nickolay A. Khazanov, Paul Williams, Armand Bankhead, Dinesh Cyanam, Supra Gajjala, Peter Wyngaard, Emma Bowden, Dan R. Rhodes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C256.
https://doi.org/10.1158/1535-7163.TARG-13-C256
Published: 01 November 2013
View article titled, Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes.